Document is current

Article History

First Online: 14 January 2019

Compliance with Ethical Standards

:

: Funding for this study TR4117387 (NCT02119260) was provided by GlaxoSmithKline. GlaxoSmithKline was involved in all aspects of this study, including design, conduct, data collection, data management, data analysis, data interpretation, and the preparation, review, and approval of the manuscript.

: All authors meet the criteria for authorship set forth by the International Committee for Medical Journal Editors. NG, PS, RS, SK, DF, and NN are employees of GSK and hold stocks in the company. The chief investigator for the study was JC, who is a Cambridge University Hospitals National Health Service Foundation Trust employee, obligated via a secondment from his employer to spend 50% of his time on clinical trials activities for GSK; however, he receives no employee benefits from GSK. JC acknowledges funding support from the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, Cambridge University Hospitals. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. AO and DLS were GSK employees at the time of the study and held stocks in the company; they have since both left the company. Editorial support (development of the first draft, assembling tables, collating author comments, and referencing) was provided by Guissou Dabiri, PhD, of GD Scientific & Medical Writing, LLC, and was funded by GSK.